ATE216366T1 - 2-aminobenzazepin-derivate und ihre verwendung für die behandlung von immunosuppression - Google Patents

2-aminobenzazepin-derivate und ihre verwendung für die behandlung von immunosuppression

Info

Publication number
ATE216366T1
ATE216366T1 AT97305934T AT97305934T ATE216366T1 AT E216366 T1 ATE216366 T1 AT E216366T1 AT 97305934 T AT97305934 T AT 97305934T AT 97305934 T AT97305934 T AT 97305934T AT E216366 T1 ATE216366 T1 AT E216366T1
Authority
AT
Austria
Prior art keywords
treatment
immunosuppression
aminobenzazepine
derivatives
cancer
Prior art date
Application number
AT97305934T
Other languages
English (en)
Inventor
Christopher B Cooper
Joseph P Lyssikatos
Donald W Mann
Scott J Hecker
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE216366T1 publication Critical patent/ATE216366T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97305934T 1996-08-16 1997-08-05 2-aminobenzazepin-derivate und ihre verwendung für die behandlung von immunosuppression ATE216366T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2342396P 1996-08-16 1996-08-16

Publications (1)

Publication Number Publication Date
ATE216366T1 true ATE216366T1 (de) 2002-05-15

Family

ID=21815010

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97305934T ATE216366T1 (de) 1996-08-16 1997-08-05 2-aminobenzazepin-derivate und ihre verwendung für die behandlung von immunosuppression

Country Status (10)

Country Link
US (1) US6043238A (de)
EP (1) EP0825186B1 (de)
JP (1) JP2978850B2 (de)
AT (1) ATE216366T1 (de)
CA (1) CA2213108C (de)
DE (1) DE69711996T2 (de)
DK (1) DK0825186T3 (de)
ES (1) ES2173391T3 (de)
MX (1) MX9706231A (de)
PT (1) PT825186E (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000076993A1 (en) * 1999-06-16 2000-12-21 Takeda Chemical Industries, Ltd. Benzazepine derivatives, process for the preparation of the same and uses thereof
SE0003795D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
TWI382019B (zh) * 2005-08-19 2013-01-11 Array Biopharma Inc 作為類鐸受體（ｔｏｌｌ-ｌｉｋｅ ｒｅｃｅｐｔｏｒ）調節劑之胺基二氮雜呯
TW201402124A (zh) 2005-08-19 2014-01-16 Array Biopharma Inc 作為類鐸受體（ｔｏｌｌ-ｌｉｋｅ ｒｅｃｅｐｔｏｒ）調節劑之８-經取代苯并氮雜呯
CA2732437C (en) 2008-08-01 2017-11-21 Ventirx Pharmaceuticals, Inc. Toll-like receptor agonist formulations and their use
ES2705101T3 (es) 2008-11-06 2019-03-21 Ventirx Pharmaceuticals Inc Métodos de síntesis de derivados de benzazepinas
DK2467380T3 (en) * 2009-08-18 2017-03-13 Ventirx Pharmaceuticals Inc SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS
CN105669553A (zh) 2009-08-18 2016-06-15 文蒂雷克斯药品公司 作为toll样受体调节剂的取代的苯并氮杂*
US10016440B2 (en) 2010-04-21 2018-07-10 Ventirx Pharmaceuticals, Inc. Methods of enhancing antibody-dependent cellular cytotoxicity
JP5985510B2 (ja) * 2011-01-12 2016-09-06 ベンティアールエックス ファーマシューティカルズ， インコーポレイテッドＶｅｎｔｉＲｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． Ｔｏｌｌ様受容体調節薬としての置換ベンゾアゼピン
WO2012097173A2 (en) * 2011-01-12 2012-07-19 Ventirx Pharmaceuticals, Inc. Substituted benzoazepines as toll-like receptor modulators
CN109153648B (zh) 2016-05-23 2022-07-22 豪夫迈·罗氏有限公司 具有叔酰胺官能团的苯并氮杂卓二甲酰胺化合物
CN109311854B (zh) 2016-05-23 2021-08-10 豪夫迈·罗氏有限公司 具有仲酰胺官能团的苯并氮杂卓二甲酰胺化合物
CN109311851B (zh) 2016-06-12 2021-08-10 豪夫迈·罗氏有限公司 二氢嘧啶基苯并氮杂䓬甲酰胺化合物
DK3595668T3 (da) 2017-03-15 2021-10-18 Silverback Therapeutics Inc Benzazepinforbindelser, konjugater og anvendelser deraf
WO2019118884A1 (en) 2017-12-15 2019-06-20 Silverback Therapeutics, Inc. Antibody construct-drug conjugate for the treatment of hepatitis
CN109956903B (zh) * 2017-12-22 2022-08-23 江苏恒瑞医药股份有限公司 苯并氮杂䓬衍生物、其制备方法及其在医药上的应用
BR112021025699A2 (pt) 2019-06-19 2022-03-03 Silverback Therapeutics Inc Anticorpos anti-mesotelina e imunoconjugados dos mesmos
JP7735291B2 (ja) 2020-02-21 2025-09-08 エーアールエス ファーマシューティカルズ、インコーポレイテッド ネクチン－４抗体コンジュゲートおよびその使用
CA3183993A1 (en) 2020-07-01 2022-01-06 Peter R. Baum Anti-asgr1 antibody conjugates and uses thereof
CA3215049A1 (en) 2021-04-10 2022-10-13 Baiteng ZHAO Folr1 binding agents, conjugates thereof and methods of using the same
AU2022262644A1 (en) 2021-04-23 2023-11-09 Genmab A/S Anti-cd70 antibodies, conjugates thereof and methods of using the same
TW202320857A (zh) 2021-07-06 2023-06-01 美商普方生物製藥美國公司 連接子、藥物連接子及其結合物及其使用方法
WO2023088420A1 (en) * 2021-11-19 2023-05-25 Chengdu Anticancer Bioscience, Ltd. 1h-benzo[b]azepin-2(3h)-one compounds, compositions and methods of treating cancer
WO2025072406A1 (en) 2023-09-26 2025-04-03 Profoundbio Us Co. Ptk7 binding agents, conjugates thereof and methods of using the same
WO2025149661A1 (en) 2024-01-10 2025-07-17 Genmab A/S Slitrk6 binding agents, conjugates thereof and methods of using the same
US20250381289A1 (en) 2024-02-29 2025-12-18 Genmab A/S Egfr and c-met bispecific binding agents, conjugates thereof and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3509130A (en) * 1966-12-09 1970-04-28 Ciba Geigy Corp 2-amino-1-benzazepines
US4968701A (en) * 1988-04-26 1990-11-06 E. I. Du Pont De Nemours And Company 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents
US5310913A (en) * 1989-06-09 1994-05-10 Kabi Pharmacia Aktiebolag Derivatives of quinoline-3-carboxanilide
US5268376A (en) * 1991-09-04 1993-12-07 Minnesota Mining And Manufacturing Company 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines

Also Published As

Publication number Publication date
EP0825186B1 (de) 2002-04-17
PT825186E (pt) 2002-08-30
CA2213108A1 (en) 1998-02-16
ES2173391T3 (es) 2002-10-16
DE69711996D1 (de) 2002-05-23
JP2978850B2 (ja) 1999-11-15
DK0825186T3 (da) 2002-07-22
MX9706231A (es) 1998-02-28
JPH1087631A (ja) 1998-04-07
US6043238A (en) 2000-03-28
EP0825186A1 (de) 1998-02-25
CA2213108C (en) 2001-12-11
DE69711996T2 (de) 2002-08-22

Similar Documents

Publication Publication Date Title
DE69711996D1 (de) 2-Aminobenzazepin-Derivate und ihre Verwendung für die Behandlung von Immunosuppression
BG105784A (en) Triazole compounds with dopamine-d3-receptor affinity
NL300216I1 (nl) Pyranonverbindingen die bruikbaar zijn voor het behandelen van retroviarale infecties.
ATE168992T1 (de) 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline
TW269678B (de)
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
PT705833E (pt) Derivado de dc-89
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
CA2096407A1 (en) Retroviral protease inhibitors
GR3033397T3 (en) Novel tetrapeptide derivative.
RU94046018A (ru) 3-арилпиразольные производные, способ их получения и фунгицидная композиция на их основе
ZA983054B (en) Fungicidal trifluoromethylalkylamino-triazolopyrimidines.
CA2188580A1 (en) N-cyanoaryl nitrogen heterocycles
RU94043771A (ru) Замещенные бензимидазольные соединения, способ лечения, фармацевтическая композиция и способ получения бензимидазольных соединений
RU95105435A (ru) N-замещенные производные 3-азабицикло [3.2.0]гептана в качестве нейролептического средства
CA2267309A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
MX9700807A (es) Derivados de 3-azabiciclo (3.2.0)heptano n-sustituidos utiles como neurolepticos.
ES2102772T3 (es) Compuesto citotoxico y antiviral.
AU1192397A (en) Substituted thiazolines and their use for controlling animal pests
FI103055B1 (fi) Menetelmä tiomarinolijohdannaisten valmistamiseksi
EP0551844A3 (de)
BR9611520A (pt) Composto hemo-reguladores.
ATE222255T1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel
DE69601451D1 (de) UCK14-Verbindungen
CA2206104A1 (en) Adamantyl substituted oxindoles as pharmaceuticals agents

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee